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Abstract
Pentachlorophenol (PCP) and dichlorodiphenyltrichloroethane (DDT), are organochlorine 
environmental contaminants found in human blood at very significant levels (as high as 5 µM for 
PCP and 260 nM for DDT). Cancers of the blood (lymphoma and myeloma) and kidney as well as 
others have been associated with exposure to these contaminants. Interleukin 1 beta (IL-1β) is a 
pro-inflammatory cytokine and is involved in stimulating cell proliferation. High levels of IL-1β 
are associated with inflammatory diseases and tumor progression. Previous studies showed that 
PCP and DDT at certain concentrations were able to stimulate secretion of IL-1β. This study 
shows that the increased secretion of IL-1β seen with both contaminants is due to compound-
induced increases in production of this cytokine. Increased production began within 6 h of 
exposure to PCP and continued to increase out to 24 h. DDT-induced stimulation of IL-1β 
appeared to be maximal after 6 h of exposure and then diminished by 24 h. The increases seen in 
IL-1β production stimulated by PCP appear to be at least partially due to compound-induced 
increases in IL-1β mRNA. Although DDT caused increased production of IL-1β, it did not appear 
to cause consistent increases in its mRNA. PCP-and DDT-induced increases in IL-1β production 
were dependent primarily on the p38 MAPK pathway. These results indicate that both PCP and 
DDT are able to increase IL1-β production in a p38 MAPK dependent manner, which may have 
the potential to influence chronic inflammation.
SHORT ABSTRACT
Production of IL-1β stimulated by PCP began within 6 h of exposure and continued to increase out 
to 24 h and DDT-induced stimulation appeared to be maximal after 6 h of exposure. Increases in 
IL-1β production by PCP are partially due to compound-induced increases in IL-1β mRNA. PCP-
and DDT-induced increases in IL-1β production were dependent primarily on the p38 MAPK 
pathway. These results indicate that PCP and DDT increase IL1-β production and have the 
potential to influence chronic inflammation.
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INTRODUCTION
Interleukin 1 beta (IL-1β) is a pro-inflammatory cytokine that has the ability to influence 
numerous cell types and contributes to several pathologies. Its roles include recruiting 
adaptive immune cells such as neutrophils, assisting with tissue repair, and stimulating the 
production of other cytokines. (Sahoo et al., 2011; Cooper et al., 2001). IL-1β plays a role in 
regulating local and systematic inflammatory responses. High levels of IL-1β can influence 
tumor growth by causing chronic inflammation. (Landskron et al., 2014). The presence of 
high IL-1β levels in the body without an infection present are connected to cardiovascular 
disease, systemic lupus erythematosus, multiple sclerosis, rheumatoid arthritis and multiple 
sclerosis to name a few (Dinarello, 1996; Braddock and Quinn, 2004; Dinarello, 2004). 
Several types of immune cells (Monocytes, T lymphocytes and NK cells) produce IL-1β and 
agents that alter their ability to synthesize IL-1β could lead to inadequate immune 
responsiveness or chronic inflammation. (Braddock and Quinn, 2004; Dinarello, 2004; Shi 
& Palmer, 2011).
Pentachlorophenol (PCP) is a chlorinated aromatic compound, it has been found in 
herbicides, insecticides, fungicides, and antifouling paint (Cirelli, 1978). PCP is use as a 
preservative to treat wooden utility poles and log cabins (Cline, et.al, 1989). Previous studies 
found that sawmill workers that were exposed to chlorophenols, as well as some of their 
children, developed leukemia, lymphoma and brain cancer (Cooper and Jones, 2008; 
Demers et al., 2006). Individuals can be exposed to PCP by absorption through skin, 
inhaling, and consumption of contaminated food or water. It has been reported in sediment 
and mussel tissues from freshwater lakes (Brown et al., 2005). PCP was found in human 
blood with serum levels ranging from 0.26 −5 µM in individuals who lived in PCP-treated 
log homes (Cline et al., 1989) and 0.15 µM in individuals with no known exposures (Cline et 
al., 1989; Uhl et al., 1986). Another organochlorine contaminant, 4, 4′-
Dichlorodiphenyltrichloroethane (4, 4′-DDT), is used as a pesticide to kill insects, mainly 
mosquitoes. Although banned in the United States it is still used in developing countries to 
control insects that spread diseases such as malaria (Rengam 2013; Davis, 2006; WHO 
2006). The lipophilic character of DDT leads to bioaccumulation and biomagnification in 
the food chain leading to high accumulation in human tissue (Koepke et al.,2004; Kodavanti 
and Loganathan, 2017). Like PCP, DDT has been found in human bodily fluid (breast milk, 
and plasma or serum) and has been detected at measurable levels in blood samples within 
the human population. DDT exposure has also been associated with a number of cancers 
(Eskenazi, et al., 2009; Harada et al., 2016).
Previous studies show PCP having the ability to increase the secretion of IL-1β from 
peripheral blood lymphocytes and monocytes at concentrations that have been measured in 
human blood. This PCP-induced increase in IL-1β secretion from immune cells utilized the 
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ERK 1/2 and p38 MAPK signaling pathways (Martin and Whalen, 2017). As seen with PCP, 
exposures to DDT also induced increased secretion of IL-1β from human peripheral blood 
immune cells (Martin and Whalen, 2017).
It is important to determine if PCP and DDT are able to increase the secretion of IL-1β by 
simply causing the cell to release a store of already existing cytokine or if they are 
stimulating immune cells to increase their production of this potent pro-inflammatory 
molecule. This study examines both intracellular and secreted levels of IL-1β from the same 
cells in response to exposures to PCP and DDT. If secretion is increased and intracellular 
levels remain unchanged or increase then increased production of IL-β has occurred. 
Concentrations of PCP and DDT that increased levels in cytokine production were further 
investigated to discover whether this was caused by increases in the mRNA for IL-1β. 
Additionally, signaling pathways known to be involved in cellular production of each of the 
cytokines were investigated for potential roles in any PCP-induced or DDT-induced 
increases in IL-1β. These included, mitogen activated protein kinases (MAPKs) and p 38 
protein kinase (Gaestel et al., 2009).
MATERIALS AND METHODS
Preparation of peripheral blood mononuclear cells (PBMCs)
PBMCs were isolated from leukocyte filters (PALL-RCPL or FLEX) obtained from the Red 
Cross Blood Bank (Nashville, TN) as described in Meyer et al., 2005. Leukocytes were 
obtained from the filters by back-flushing the filters with an elution medium (sterile PBS 
containing 5 mM disodium EDTA and 2.5% [w/v] sucrose) and then collecting the eluent. 
The eluent was layered onto Lymphosep® (1.077g/mL) and centrifuged at 1200g for 30 
min. Following centrifuging and washing, the cells were layered on bovine calf serum for 
platelet removal. The cells were then suspended in RPMI-1640 complete medium, which 
consisted of RPMI-1640 supplemented with 10% heat-inactivated BCS, 2 mM L-glutamine 
and 50 U penicillin G with 50 μg streptomycin/mL.
Chemical Preparation
DDT and PCP were purchased from Sigma-Aldrich (St. Louis, MO). Stock solutions were 
prepared as 100 mM solutions in Dimethyl sulfoxide (DMSO). Desired concentrations were 
prepared of either DDT or PCP by dilution of the desired stock into cell culture media.
Inhibitor Preparation
Enzyme inhibitors were purchased from Fischer Scientific (Pittsburgh, PA). The stock 
solution for each inhibitor was a 50 mM solution in dimethyl sulfoxide (DMSO). MEK 1/2 
pathway inhibitor (PD98059), p38 inhibitor (SB202190) were prepared by dilution of the 
stocks.
Cell lysis and collection of supernatants for production studies
PBMCs were treated with 5–0.05 µM PCP and 2.5–0.025 µM DDT or control for 10 min, 1 
h, 6 h or 24 h. Following the treatments, the cells were centrifuged, supernatants collected, 
and the cell pellets lysed using 133 µL of lysis buffer (Active motif, Carlsbad, CA) per 3–4 
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million cells. The cell lysates were stored frozen at −80 o C up to the point when they were 
run on SDS-PAGE. All controls and PCP/DDT-exposed cells for a given experimental set-up 
were from an individual donor. Each of the experimental set-ups was repeated a minimum of 
four times using cells from different donors. For the pathway inhibitor experiments, PBMCs 
were treated with enzyme inhibitors 1h prior to adding PCP at concentrations of 5, 2.5, and 1 
μM for 24 h or DDT at concentrations of 0.1, 0.05, and 0.025 μM for 6 h. After the cells 
were incubated, the cells were pelleted, and supernatants were obtained and stored at −80 o 
C until assaying for the IL-1β cytokine and the pellet was lysed for future analysis by 
western blot.
IL-1β Secretion Assay
Levels of secreted IL-1β were measured using the BD OptEIA™ Human IL-1β enzyme-
linked immunosorbent assay (ELISA) kit (BD-Pharmingen, San Diego, CA). This kit is 
highly selective for IL-1β and does not cross react with other proteins including other 
cytokines. A 96-well micro well plate, designed for ELISA assays (Fisher, Pittsburgh, PA), 
was coated with a capture antibody for IL-1β that was diluted in coating buffer. The ELISA 
plate was incubated with the capture antibody overnight at 4 ˚C. After the incubation, the 
capture antibody was removed and blocking solution (PBS and bovine calf serum) was 
added to each well and incubated at room temperature for 1h. Following the blocking step, 
cell supernatants and IL-1β standards were added to the plate and incubated for 2 h at room 
temperature. Detection antibody linked to horseradish peroxidase (HRP) was then added 
followed by substrate. The reaction was stopped by addition of 1 M phosphoric acid and 
absorbance was measured at 450 nm on a Thermo Labsystems Multiskan MCC/340 plate 
reader (Fisher Scientific).
Western blot
Cell lysates were run on 10% SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel 
electrophoresis) and transferred to a PVDF (polyvinylidene difluoride) membrane. The 
PVDF was immunoblotted with specific primary antibodies: IL-1β (Cell Signaling 
Technology, Danvers, MA), and actin (Sigma). Antibodies were visualized using the UVP 
Imager. The density of each protein band was determined by densitometric analysis using 
the UVP image analysis software. The samples from all the experimental set-ups were run 
on a separate gel/blot. A given experimental set-up had its own internal control. Differences 
in protein expression were determined relative to the internal control, which provided 
quantitation by evaluating whether a given treatment altered these proteins relative to 
untreated cells. β-Actin levels were determined for each condition to verify that equal 
amounts of protein were loaded. In addition, the density of each protein band was 
normalized to β-actin to correct for minor differences in protein loading among the lanes.
RNA Isolation and RT-qPCR
PBMCs (2–4 million cells) were extracted with RNeasy Mini Kit (Qiagen, Venlo, 
Netherlands). RNA concentrations were measured with a Nanodrop spectrophotometer 
(Nanodrop Technologies, Wilmington, DE). PCR primers were designed using Primer 
Express 2.0 (Applied Biosystems, Foster City, CA). All RT-qPCR assays were conducted 
using QuantiTect SYBR Green RT-PCR kit (Qiagen). Reactions were done in 20 µL 
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containing 50 ng of total RNA and 0.4 µM of each primer. Thermal cycles contained one 
cycle of pre-incubation at 50∘C for 10 minutes and 95∘C for 15 minutes, 35 cycles of 
amplification (95∘C for 15 seconds and 60∘C for 60 seconds). Primers were validated by a 
melting curve analysis. For standard curve analysis, an RNA pool was made, serial diluted, 
and measured again with spectrophotometer.
Statistical Analysis
Statistical analysis of the data was done using ANOVA and the Student’s t test. Data were 
initially compared within a given experimental setup by ANOVA. A significant ANOVA 
evaluation was followed by pair wise analysis of control versus exposed data using Student’s 
t test, a p value of less than 0.05 was considered significant.
RESULTS
Effects of exposures to PCP on the Production (Secretion + Intracellular Levels) of IL-1β.
10 min exposure: The effects of 10 min exposures to PCP on intracellular and secreted 
levels of IL-1β were examined in PBMCs from 4 separate donors. If there is an increase in 
secretion and no accompanying decrease in the intracellular level of IL-1β (or an increase in 
the intracellular level), this indicates that there is an increase in production of the cytokine. 
There were no consistent increases in the production of IL-1β after 10 min exposures to PCP 
(data not shown).
1h exposure: Similar to what was seen at 10 min., there were no consistent increases in 
the production of IL-1β (secretion + intracellular levels) when cells from 4 separate donors 
were exposure to PCP for 1 h. Data not shown.
6 h exposure: The effects of 6 h exposures to PCP on production of IL-1β are shown in 
Figure 1A and Table 1 (PBMCs from 4 separate donors). Figure 1 shows the data from the 
cells from a representative experiment (donor F494) where there were increases in 
production of IL-1β of approximately 2 fold at every level of PCP to which the cells were 
exposed. There were consistent increases in the production of IL-1β (secretion + 
intracellular levels) after 6-hours of exposure to PCP in cells from every donor at multiple 
PCP concentrations (Table 1). These results indicate that PCP stimulates IL-1β production in 
PBMCs within 6 hours of exposure.
24 h exposure: When PBMCs were exposed to PCP for 24 h, there was an increase in 
production of IL-1β. For a representative experiment (Figure 1B, donor F481), increases of 
approximately 2–4 fold were seen at every PCP exposure level (0.05–5 µM). Table 1 
summarizes the effects of PCP on IL-1β production in cells from 3 additional donors. Cells 
from all donors showed increases in the production of IL-1β after 24-hours of exposure to 
PCP.
Effects of 2 h, 6 h, and 24 h exposures to PCP on IL-1β mRNA levels in PBMCs
Figure 2 shows the levels of IL-1β mRNA in PBMCs exposed to PCP concentrations 
ranging from 0.05 µM-5 µM for 2 h, 6 h, and 24 h. Exposure to PCP for 2 h caused no 
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notable changes in the levels of IL-1β mRNA in cells from any of the 4 donors tested. After 
a 6 h exposure, cells from 2 donors (F538 and F541) showed PCP-induced increases in 
IL-1β mRNA while cells from the other 2 donors showed no increases (Figure 2). For cells 
from donor F538 fold increases ranged between 1.3–1.7 and in those from F541 fold 
increase ranged between 1.5–2.5. When cells were exposed to PCP for 24 h, there were 
PCP-induced increases in IL-1β mRNA seen in 4 of the 5 donors tested (Figure 2). Thus, it 
appears that PCP may lead to increases in IL-1β production, at least in part, by increasing 
the levels of IL-1β mRNA.
Effects of exposures to PCP on the production of IL-1β in PBMCs when the p44/42 and p38 
signaling pathways are inhibited
Inhibition of p44/42 pathway by PD98059—Figure 3A (representative experiment) 
and Table 2 show the effects of 24 h exposures to 1, 2.5, and 5 μM PCP on IL-1β production 
in PBMCs when the p44/42 MAP kinase pathway was inhibited with PD98059. When the 
inhibitor was present, PBMCs from 2 of the 4 donors continued to show PCP-stimulated 
production of IL-1β. For instance, when cells from donor F569 were exposed to 1, 2.5, and 5 
μM PCP in the absence of PD98059 inhibitor there were 1.2, 2.6, and 2.9 fold increases in 
IL-1β production. When the inhibitor was present those same PCP exposures caused 1.7, 
3.2, and 5.3 fold increases at 1, 2.5, 5 µM exposures to PCP (Table 2). However, in cells 
from donor F582 increases in IL-1β production were 6.5, 6.0, and 6.2 fold at 1, 2.5, and 
5µM PCP in the absence of inhibitor but were decreased to nothing, 1.8 and 1.2 fold, 
respectively, when the inhibitor was present (Table 2). Overall, the results indicate that the 
p44/42 pathway is utilized by PCP to stimulate IL-1β production in cells from some donors.
Inhibition of p38 pathway by SB202190—The effect of p38 MAPK pathway 
inhibition on PCP-induced increases in IL-1β production from PBMCs are shown in Figure 
3B (representative experiment) and Table 2. All donors consistently showed lowered PCP-
induced IL-1β production in the presence of SB202190. For example, donor F598 showed 
5.2, 6.7, and 4.4 fold increases when PBMCs were exposed to 1, 2.5 and 5 µM PCP in the 
absence of the p38 inhibitor. When the inhibitor was present, those same PCP exposures 
caused no measurable increases in IL-1β production. These data indicate that PCP utilizes 
the p38 pathway to stimulate IL-1β production in PBMCs.
Effects of DDT Exposures on the Production (Secretion + Intracellular Levels) of IL-1β
1h exposure: When PBMCs were exposed to DDT (0.025 −2.5 µM) for 1 h, there were 
increases in production of IL-1β in cells from 4 donors tested (Figure 4A and Table 3). For 
example the cells from donor F558 showed increases of 2.1, 1.4, 2.0, 2.0, and 1.5 fold at the 
2.5, 1, 0.5,0.25, and 0.1 µM DDT concentrations (Figure 4A).
6 h exposure: Exposures of PBMCs from 4 separate donors to DDT for 6 h on production 
(intracellular and secreted levels) of IL-1β were examined. Figure 4B and Table 3 shows 
increases in production occurred in all donors at five or more concentrations or DDT. F543 
shows fold increases ranging from 1.9–5.5 (Figure 4B). These data indicate that there are 
consistent increases in the production of IL-1β within 6 h of exposure to multiple 
concentrations of DDT.
Martin et al. Page 6













24 h exposures: The effects of 24 h exposures to DDT on production of IL-1β were 
examined in PBMCs from 4 separate donors are shown in Figure 4C and Table 3. Cell from 
all donors showed DDT-induced increases in IL-1β production at one or more concentration. 
Figure 4C shows that there were increases of 1.1, 1.8, 2.2, 1.2, 1.7, 1.9 and 1.1 fold at 
concentration of 2.5, 1, 0.5, 0.25, 0.1, 0.05, and 0.25 µM DDT. However, the increases were 
seen at fewer total DDT concentrations overall after 24 h than were seen after 1 h and 6 h of 
exposure.
Effects of 2 h and 6 h exposures to DDT on IL-1β mRNA levels in PBMCs
Figure 5 shows IL-1β mRNA expression in PBMCs from 4 separate donors exposed to DDT 
concentrations ranging from 0.025–2.5 µM for 2 h and 6 h. There are not consistent 
increases in IL-1β mRNA after either length of exposure. In contrast to the effects seen with 
PCP, it does not appear that the DDT-induced increases in IL-1β production can be 
accounted for by increases in IL-1β mRNA.
Effects of exposures to DDT on the production of IL-1β in PBMCs when the p44/42 and p38 
signaling pathways are inhibited
Inhibition of p44/42 pathway by PD98059—The effects of 6 h exposures to 0.025, 
0.05, and 0.1 μM DDT on production of IL-1β from PBMCs where p44/42 MAPK pathway 
function had been inhibited with PD98059 are shown in Figure 6A and Table 4. Cells 
exposed to DDT when the inhibitor was present showed diminished DDT-stimulated 
production of IL-1β in three out of four donors. Overall, the results indicate that the p44/42 
MAPK pathway may be being utilized to some extent by DDT to lead to increases in IL-1β 
production in the PBMCs.
Inhibition of p38 pathway by SB202190—The effect of p38 MAPK pathway 
inhibition on DDT-induced increases in IL-1β production from PBMCs (6 h exposures) are 
shown in Figure 6B and Table 4. Three out of 4 donors consistently showed lowered DDT-
induced IL-1β production in the presence of SB202190. For example, donor F591 showed 
2.6, 1.8, and 3.5 fold increases in IL-1β production when PBMCs were exposed to 0.025, 
0.05 and 0.1 µM DDT in the absence of the p38 inhibitor. When the inhibitor was present, 
those same DDT exposures caused 1.6, 1.3, and 1.8 fold increases. This indicates that the 
p38 pathway is likely being utilized by DDT to stimulate IL-1β production.
DISCUSSION
IL-1β can significantly contribute to a number of diseases when its levels are elevated in the 
absence of infection or injury, producing a state of chronic inflammation. Tumor growth, 
rheumatoid arthritis, Crohn’s disease, and multiple sclerosis are some of the pathologies 
associated with chronic inflammation (Landskron et al., 2014; Choy and Panayi, 2001; 
Dinarello, 2011; Rossi et al., 2012; Elaraj et al., 2006; Jin et al., 1997; Lewis and Varghese, 
2006; Voronov et al., 2002; Rubin et al., 2012; Shamesh et al., 2002; Straub et al., 2016). 
PCP is an environmental contaminant found in human blood with serum levels ranging as 
high as 5 μM (Cline et al., 1989; Uhl et al., 1986). PCP exposure has been associated with a 
number of malignancies in humans including cancers of the blood (lymphoma and 
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myeloma) and kidney (Demers et al., 2006; Cooper & Jones, 2008). DDT is another 
organochlorine compound that continues to contaminate the environment, primarily due to 
its past and current use as an insecticide. Although DDT usage is banned in many 
industrialized countries, due to its destructive and intense effects on the environment, it is 
still used in developing countries for public health purposes (Turusov et al., 2002; 
Loganathan, 2016). DDT has been discovered in serum at levels as high as 23, 169 ng/g of 
lipid (approximately 260 nM) (Koepke et al., 2004; Trejo-Acevedo et al., 2009). Both PCP 
and DDT have also been shown to increase IL-1β secretion from human immune cells 
(Martin and Whalen,2017). However, it was not possible to tell from those studies whether 
PCP and DDT were simply increasing the release of pre-existing IL-1β or if they were able 
to stimulate immune cells to produce these cytokines. The later effect would have greater 
capacity to induce sustained inflammation than would the former. Thus, studies were carried 
out to determine if either PCP or DDT were able to stimulate production of IL-1β. If PCP 
and DDT are only stimulating the release of IL-1β that already exists in the cell, then there 
will be a limit to their ability to increase the levels of IL-1β secreted by immune cells. On 
the other hand, if PCP or DDT stimulate production of IL-1β by immune cells this could 
provide sustained elevation of this cytokine and lead to chronic inflammation.
The results indicated that PCP exposures stimulated IL-1β production after 6 h and these 
compound-induced increases maintained and intensified out to 24 h. Results after 6 h 
showed that PCP increased IL-1β production in all donors at one or more concentrations. 
After 24 h PCP-stimulated IL-1β production occurred consistently in all donors at PCP 
concentrations of 0.1–5 µM. DDT also induced increases in IL-1β production, however 
unlike PCP, DDT seemed to maximally stimulate the production IL-1β at earlier time points 
(1 h and 6 h) rather than after 24 h of exposure. Significant increases that were seen in IL-1β 
production from PCP and DDT exposures could be due to increased translation/
transcription, mRNA stability, protein stability or a combination of these factors. Thus, 
studies were carried out to investigate the effects of each contaminant on the levels of IL-1β 
mRNA in PBMCs. It appears that PCP-induced increases in production of IL-1β can at least 
be partially attributed to compound-stimulated increases in the mRNA for the cytokine. 
While, DDT caused consistent increases in IL-1β production, it did not produce consistent 
increases in the mRNA for IL-1β within the 6 h time frame. Thus, it appears that PCP is able 
to stimulate increased IL-1β production at least in part by increasing its mRNA. In contrast, 
the increase in production of IL-1β stimulated by DDT does not appear to be the result of 
increases in the mRNA for IL-1β. Thus, further studies examining the role of contaminant-
stimulated increases in translation or decreases in protein degradation are warranted.
The roles of certain signaling pathways in PCP and DDT-induced increases in production of 
IL-1β in PBMCs were also investigated. The mitogen activated protein kinase (MAPK) 
pathways, p44/42 and p38 are known to be involved in regulating the production of IL-1β 
cytokines in immune cells (Gaestel et al., 2009). The results of these studies indicated that 
PCP may utilize p44/42 pathway in some donors to increase IL-1β production. PCP appears 
to consistently rely upon the p38 pathway to produce increased production of IL-1β. The 
roles of these same pathways in DDT-induced increases in production of IL-1β were also 
studied. As was seen with PCP, DDT may utilize p44/42 pathway to a certain extent in 
increasing IL-1β production. Like PCP, DDT appears to require the p38 pathway to 
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stimulate IL-1β production. These results can be compared with those seen with the 
organotin contaminant, TBT. TBT like PCP and DDT appears to predominantly rely on the 
p38 pathway, and has some requirement for the p44/42 pathway in order to stimulate IL-1β 
production in immune cells (Brown et. al, 2018). Additionally, activation of p38 by DDT 
and its metabolites leads to altered gene expression in a human embryonic kidney epithelial 
cell line and in an endometrial cell line (Frigo et al., 2004;) and apoptosis in cultured rat 
sertoli cells (Song, et al., 2011)
Other contaminants such as the brominated flame retardant hexabromocyclododecane 
(HBCD) have been shown to increase the secretion of IL-1β from human immune cells 
(Anisuzzaman and Whalen, 2016). Organotin contaminants, tributylin (TBT) and dibutyltin 
(DBT) also increase IL-1β secretion from human lymphocytes and monocytes (Brown and 
Whalen, 2015; Brown et al.,2017). Additionally, TBT can significantly increase the 
production of IL-1β in lymphocytes. Production begins to increase after 6 h exposure and 
continued to increase after 24h exposure (Brown et. al, 2018). TBT’s ability to alter 
production can be partially attributed to increases in mRNA for IL-1β (Brown et al., 2018). 
Due to the importance of IL-1β in normal immune function and in the development of 
chronic inflammation leading to certain disease states such as rheumatoid arthritis, it is 
important to understand the role of the array of contaminants that humans are exposed to in 
altering appropriate levels of these proteins.
In summary, PCP caused increased production of IL-1β after 6 h exposures and the increases 
continued and intensified out to 24 h. In contrast, DDT caused maximal IL-1β production 
within 6 h, which then appeared to diminish between 6 and 24 h. PCP-stimulated increases 
in mRNA for IL-1β appear to at least partially explain its ability to increase IL-1β 
production, while this does not appear to be the case for DDT. Furthermore, results indicate 
that the p38 MAPK pathway appears to be required for both PCP-and DDT-induced 
increases in IL-1β production. The p44/p42 pathway is also utilized by each compound to 
increase IL-1β production, but not in cells from all donors.
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Effects of exposures to PCP on IL-1β production in PBMCs. A) 6 h exposure to 0–5 µM 
PCP. The blot is from a representative experiment (F494) with accompanying secretion data. 
An increase in secretion or in intracellular level is a number greater than 1; a decrease in 
secretion compared to the control is a number less than 1. The control is arbitrarily set at 1. 
A combined fold increase (secretion + intracellular) greater than 1 indicates an increase in 
production. Changes in fold production for 3 additional experiments are given in Table 1. B) 
24 h exposure to 0–5 µM PCP. The blot is from a representative experiment (F481) with 
accompanying secretion data. Changes in fold production for 3 additional experiments are 
given in Table 1.
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Effects of 2 h, 6 h, and 24 h exposures to PCP on IL-1β mRNA levels in PBMCs. Data are 
from cells isolated from 4 different donors for the 2 h and 6 h exposures and from 5 different 
donors for 24 h exposures (individual donor designation is indicated in the figure). Values 
are the mean ±S.D. of triplicate determinations. Statistically significant increases (P<0.05) in 
mRNA compared to the control are indicated by (+).
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Effects of the inhibition of selected signaling pathways on IL-1β production in PBMCs 
exposed to PCP for 24 h. A) MEK inhibitor (PD98059). Data is from a representative 
experiment (F570). Data from additional experiments are given in Table 3; B) p38 inhibitor 
(SB202190) Data is from a representative experiment (F570). Data from additional 
experiments are given in Table 2. An increase in secretion or in intracellular level is a 
number greater than 1 a decrease in secretion compared to the control is a number less than 
1. The control is arbitrarily set at 1. Cells treated with inhibitor are compared to control cells 
treated with inhibitor. A combined fold increase (secretion + intracellular) greater than 1 
indicates an increase in production.
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Effects of exposures to DDT on IL-1 β production in PBMCs. A) 1 h exposure to 0–2.5 µM 
DDT. The blot is from a representative experiment (F558) with accompanying secretion 
data. B) 6 h exposure to 0–2.5 µM DDT. The blot is from a representative experiment 
(F543) with accompanying secretion data. C) 24 h exposure to 0–2.5 µM DDT. The blot is 
from a representative experiment (F518) with accompanying secretion data. An increase in 
secretion or in intracellular level is a number greater than 1; a decrease in secretion 
compared to the control is a number less than 1. The control is arbitrarily set at 1. A 
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combined fold increase (secretion + intracellular) greater than 1 indicates an increase in 
production. Changes in fold production for 3 additional experiments at each length of 
exposure are given in Table 3.
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Effects of 2 h and 6 h exposures to DDT on IL-1β mRNA levels in PBMCs. Data are from 
cells isolated from 4 different donors (individual donor designation is indicated in the 
figure). Values are the mean ±S.D. of triplicate determinations. Statistically significant 
increases (P<0.05) in mRNA compared to the control are indicated by (+).
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Effects of the inhibition of selected signaling pathways on IL-1β production in PBMCs 
exposed to DDT for 6 h. A) MEK inhibitor (PD98059). Data is from a representative 
experiment (F592). Data from additional experiments are given in Table 4; B) p38 inhibitor 
(SB202190) Data is from a representative experiment (F592). Data from additional 
experiments are given in Table 4. An increase in secretion or in intracellular level is a 
number greater than 1 a decrease in secretion compared to the control is a number less than 
1. The control is arbitrarily set at 1. Cells treated with inhibitor are compared to control cells 
treated with inhibitor. A combined fold increase (secretion + intracellular) greater than 1 
indicates an increase in production.
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Table 1:
Effects of PCP exposures on production of IL-1β in PBMCS after 6 h and 24 h
Fold increase in production IL-1 β
[PCP] µM 5 2.5 1 0.5 0.25 0.1 0.05
Exposure time donor
6h F490 2.4 2.3 1.6 1.8 1.8 1.8 NI
F492 1.5 1.4 1.1 2.3 2.5 2.2 NI
F493 1.7 1.7 1.4 1.1 NI NI NI
24 h F444 5.1 2.8 2.0 2.0 2.3 2.6 2.5
F451 3.3 4.1 1.6 NI 1.4 1.3 NI
F485 3.2 4.0 2.3 1.2 1.3 1.1 1.4
NI indicates no significant increase ( Fold increase ≤1)
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Table 2:
Effects of PCP exposure on the production of IL-1β in PBMCS when the p44/42 or p38 signaling pathways 
are inhibited.
Fold increase in production IL-1 β
[PCP] µM 5 2.5 1 5+I 2.5+I 1+I
Inhibitor (I) donor
PD98059 F569 2.9 2.6 1.2 5.3 3.2 1.7
F571 1.8 NI NI 1.4 1.1 NI
F582 6.2 6.0 6.5 1.2 1.8 NI
SB202190 F571 NI 1.4 NI NI NI NI
F582 1.4 1.5 1.2 NI NI NI
F598 4.4 6.7 5.2 NI NI NI
NI indicates no significant increase ( Fold increase ≤1)
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Table 3:
Effects of DDT exposures on production of IL-1β in PBMCS after 1 h, 6 h, and 24 h
Fold increase in production IL-1 β
[DDT] µM 2.5 1 0.5 0.25 0.1 0.05 0.025
Exposure time donor
1h F557 1.8 1.6 4.9 8.4 7.4 6.2 5.8
F560 1.8 1.1 1.5 1.3 1.3 1.1 1.2
F561 NI NI NI 2.1 NI 2.3 2.4
6 h F535 NI NI 1.8 2.6 2.0 3.8 3.3
F536 1.3 NI 1.2 1.4 1.3 1.2 NI
F545 NI 1.1 1.1 NI 1.1 1.2 1.3
24 h F517 NI NI NI NI NI 1.3 NI
F522 2.8 4.0 5.0 4.0 3.6 2.5 2.9
F523 1.5 NI NI NI NI NI NI
NI indicates no significant increase ( Fold increase ≤1)
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Table 4:
Effects of DDT exposure on the production of IL-1β in PBMCS when the p44/42 or p38 signaling pathways 
are inhibited.
Fold increase in production IL-1 β
[DDT] µM 0.1 0.05 1 0.1+I 0.05+I 0.025+I
Inhibitor (I) donor
PD98059 F590 1.2 NI NI 1.2 NI 1.2
F591 5.9 3.8 8.1 4.2 4.5 3.9
F593 2.7 2.4 3.6 2.1 2.0 3.1
SB202190 F591 3.5 1.8 2.6 1.7 1.3 1.6
F593 2.4 3.0 3.0 2.2 2.2 1.9
F595 NI 1.1 NI 1.2 1.4 1.1
NI indicates no significant increase ( Fold increase ≤1)
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